Once Upon A Farm, PBC
OFRMOnce Upon A Farm, PBC's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Once Upon A Farm, PBC trades at $17.2, between stages. It sits at 25% of a 52-week range of $15 to $24. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week.
Today the stock is between stages. At $17.2 it trades near its long-run average and sits at 25% of its 52-week range ($15–$24).
Against the market, two honest reads. Cumulative: over the last 6 months the stock moved −21% while the S&P 500 moved +13% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
P/E does not price Once Upon A Farm, PBC — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. On sales the market values Once Upon A Farm, PBC at 4.2× its FY25 revenue of $0.2 B.
With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Once Upon A Farm, PBC reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 5 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +50.0% | — | — | — |
4-Factor Sector Score
45.1/100 — rank 29 of 30 in Packaged Foods · 28% evidence confidence · provisional, ranked below fully-evidenced peers
Once Upon A Farm, PBC scores 45.1 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 29. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 19.6 + 5.5 + 10 + 10 = 45.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Once Upon A Farm, PBC reported $0.1 B of revenue in the Mar 26 quarter, +40.0% year on year. That is the 5th straight quarter of year-on-year growth. Over 2 years it has compounded at 63.3% a year. The last full year, FY25, came in at $0.2 B. The last four reported quarters add to $0.3 B.
FY25 revenue came in at $0.2 B (+50.0% on the year), capping 2 years at 63.3% compound. The latest quarter (Mar 26) printed $0.1 B, +40.0% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +58.8% growth against the decade's 63.3% — the current year is running slower than its own long-run rate.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Once Upon A Farm, PBC's operating margin is −28.6% in the Mar 26 quarter, −8.6 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −22.2% to −4.2%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −28.6%, −8.6 pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −22.2%–−4.2%.
🚨 Why the margin moved: operating margin went −8.6 pp year on year while gross margin went +2.9 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Once Upon A Farm, PBC posted a net loss of $0.02 B in the Mar 26 quarter. The full FY25 year was a loss of $0.02 B. That loss is 28.6% of the quarter's revenue. The same quarter a year earlier lost $0.02 B. 6 of the last 9 reported quarters were loss-making.
Mar 26 profit was $−0.0 B, null year on year. On the full year, FY25 printed $−0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Once Upon A Farm, PBC's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $−0.0 B of operating cash against $−0.0 B of profit. After $0.0 B of capital spending, $−0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $−0.0 B against reported profit of $−0.0 B, leaving free cash of $−0.0 B after $0.0 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Once Upon A Farm, PBC does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Once Upon A Farm, PBC earns a ROE of 100% in FY25. That is up from a trough of −200% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −8.3% net margin on 2.00× asset turns.
FY25 ROE is 100%, recovered from a FY23 trough of −200% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): −8.3% net margin × 2.00× asset turns × −6.00× balance-sheet leverage ≈ 99.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Dividend
Once Upon A Farm, PBC pays no dividend. Across the last 9 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Once Upon A Farm, PBC does not currently pay a dividend. Across the last 9 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Once Upon A Farm, PBC carries total debt of $0.0 B against shareholder equity of $0.2 B as of Mar 26, a debt-to-equity of 0.00 — effectively unlevered. On the annual view that ratio went from 2.00 in FY23 to −3.00 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of $0.0 B against shareholder equity of $0.2 B — a debt-to-equity of 0.00. On the annual view, debt-to-equity went from 2.00 (FY23) to −3.00 (FY25). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
40.0% of Once Upon A Farm, PBC's tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 8.1 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 40.0% of the float is sold short, and at typical trading volumes it would take about 8.1 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Once Upon A Farm, PBC: the Z-score reads 11.40. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 11.40 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 11.40.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Seneca Foods CorporationSENEA | 65.4/100Thin evidence · provisional60% evidence | TURNING | 22.9/35 Revenue 5.1% · PAT 100% · OPM change 5.4 pp 53% evidence | 10.8/25 ROCE 2.3% · OPM 6% 57% evidence | 15.7/20 P/E 9.1× · PEG 0.28 65% evidence | 16.0/20 RS sector 25.6% · RS bench 18.5% · 1Y 69%5 of 12 weeks ahead 70% evidence |
| Exact sum: 22.9 + 10.8 + 15.7 + 16 = 65.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Darling Ingredients Inc.DAR | 62.8/100Thin evidence · provisional56% evidence | ASLEEP | 23.2/35 Revenue — · PAT — · OPM change 9.5 pp 39% evidence | 17.1/25 ROCE 12% · OPM 14.6% 76% evidence | 9.8/20 P/E 15.2× · PEG — 15% evidence | 12.7/20 RS sector 22.3% · RS bench 16.1% · 1Y 96.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23.2 + 17.1 + 9.8 + 12.7 = 62.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Central Garden & Pet CompanyCENT | 62.5/100Mixed-positive evidence66% evidence | BREAKING OUT | 19.7/35 Revenue 0.2% · PAT 37.9% · OPM change 0.8 pp 53% evidence | 13.6/25 ROCE 8.8% · OPM 12.6% 57% evidence | 15.1/20 P/E 12.1× · PEG 0.25 65% evidence | 14.1/20 RS sector 15.4% · RS bench 8.4% · 1Y 29.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 13.6 + 15.1 + 14.1 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Mama's Creations, Inc.MAMA | 59.9/100Mixed-positive evidence81% evidence | BREAKING OUT | 24.5/35 Revenue 46.5% · PAT 50% · OPM change 0.5 pp 83% evidence | 11.3/25 ROCE 5.3% · OPM 5% 76% evidence | 5.6/20 P/E 94.6× · PEG 2.6 65% evidence | 18.5/20 RS sector 30.7% · RS bench 23.5% · 1Y 135.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 11.3 + 5.6 + 18.5 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5The J. M. Smucker CompanySJM | 59.7/100Mixed-positive evidence64% evidence | BREAKING OUT | 22.5/35 Revenue 3.7% · PAT — · OPM change 47.5 pp 62% evidence | 12.9/25 ROCE 3.1% · OPM 19.6% 76% evidence | 9.1/20 P/E 23× · PEG — 15% evidence | 15.2/20 RS sector 7.9% · RS bench 0.9% · 1Y 7.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 12.9 + 9.1 + 15.2 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6John B. Sanfilippo & Son, Inc.JBSS | 58.8/100Thin evidence · provisional60% evidence | TURNING | 16.6/35 Revenue 5.1% · PAT 21.4% · OPM change -2.4 pp 53% evidence | 13.8/25 ROCE 5.2% · OPM 8.4% 57% evidence | 13.9/20 P/E 13.6× · PEG 0.67 65% evidence | 14.5/20 RS sector 8.5% · RS bench 2% · 1Y 34%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.6 + 13.8 + 13.9 + 14.5 = 58.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7The Campbell's CompanyCPB | 56.0/100Mixed-positive evidence81% evidence | TURNING | 22.1/35 Revenue -2.9% · PAT 33.9% · OPM change 3.6 pp 83% evidence | 11.8/25 ROCE 2% · OPM 10.1% 76% evidence | 15.2/20 P/E 10.3× · PEG 0.3 65% evidence | 6.9/20 RS sector -16.8% · RS bench -23.1% · 1Y -29.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 11.8 + 15.2 + 6.9 = 56 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Smithfield Foods, Inc.SFD | 51.3/100Mixed-positive evidence66% evidence | BASING | 17.4/35 Revenue 7.5% · PAT 12.1% · OPM change 0.3 pp 53% evidence | 13.4/25 ROCE 3.1% · OPM 8.8% 57% evidence | 13.5/20 P/E 10.4× · PEG 0.96 65% evidence | 7.0/20 RS sector -0.8% · RS bench -7% · 1Y -0.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 13.4 + 13.5 + 7 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Lamb Weston Holdings, Inc.LW | 50.6/100Thin evidence · provisional56% evidence | TURNING | 14.9/35 Revenue — · PAT — · OPM change -8.3 pp 39% evidence | 12.0/25 ROCE 2.8% · OPM 8.1% 76% evidence | 9.5/20 P/E 20.8× · PEG — 15% evidence | 14.2/20 RS sector 2.4% · RS bench -4.8% · 1Y 3.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 12 + 9.5 + 14.2 = 50.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Utz Brands, Inc.UTZ | 50.4/100Thin evidence · provisional56% evidence | TURNING | 14.7/35 Revenue 2.3% · PAT -144.1% · OPM change 0.6 pp 53% evidence | 7.3/25 ROCE 0.3% · OPM 2.2% 57% evidence | 8.5/20 P/E 1046× · PEG — 15% evidence | 19.9/20 RS sector 37.4% · RS bench 27% · 1Y 10.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 7.3 + 8.5 + 19.9 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11JBS N.V.JBS | 47.6/100Thin evidence · provisional60% evidence | BASING | 15.5/35 Revenue 12.1% · PAT -11.3% · OPM change -2.3 pp 53% evidence | 9.6/25 ROCE 1.5% · OPM 2.2% 57% evidence | 15.5/20 P/E 11.3× · PEG 0.16 65% evidence | 7.0/20 RS sector -9.9% · RS bench -16% · 1Y -4.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 15.5 + 9.6 + 15.5 + 7 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12The Kraft Heinz CompanyKHC | 47.0/100Thin evidence · provisional56% evidence | TURNING | 13.4/35 Revenue -1.8% · PAT -317% · OPM change -1 pp 53% evidence | 11.4/25 ROCE 1.5% · OPM 18.9% 57% evidence | 9.9/20 P/E 13.8× · PEG — 15% evidence | 12.3/20 RS sector 4.2% · RS bench -2.7% · 1Y -4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 13.4 + 11.4 + 9.9 + 12.3 = 47 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Hormel Foods CorporationHRL | 46.3/100Mixed-negative evidence71% evidence | BREAKING OUT | 13.1/35 Revenue 2.5% · PAT -37.6% · OPM change -1.3 pp 83% evidence | 10.7/25 ROCE 1.8% · OPM 7.3% 76% evidence | 8.9/20 P/E 25.4× · PEG — 15% evidence | 13.6/20 RS sector 2% · RS bench -4.9% · 1Y -11%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 10.7 + 8.9 + 13.6 = 46.3 · Decision use: Price leads the evidence: RS versus the benchmark is -4.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 14Ingredion IncorporatedINGR | 45.4/100Mixed-negative evidence66% evidence | BASING | 14.4/35 Revenue -2.2% · PAT 7.2% · OPM change -3.9 pp 53% evidence | 14.0/25 ROCE 3.1% · OPM 11.3% 57% evidence | 12.5/20 P/E 10.9× · PEG 1.14 65% evidence | 4.5/20 RS sector -10.3% · RS bench -16.5% · 1Y -17.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 14 + 12.5 + 4.5 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15McCormick & Company, IncorporatedMKC | 45.3/100Mixed-negative evidence81% evidence | TURNING | 18.4/35 Revenue 9.5% · PAT 1.1% · OPM change -0.5 pp 83% evidence | 14.2/25 ROCE 2.4% · OPM 14.3% 76% evidence | 6.7/20 P/E 7.9× · PEG 4.94 65% evidence | 6.0/20 RS sector -16.9% · RS bench -23% · 1Y -26%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 14.2 + 6.7 + 6 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16BellRing Brands, Inc.BRBR | 45.3/100Thin evidence · provisional60% evidence | TURNING | 13.0/35 Revenue 6.4% · PAT -43.6% · OPM change -5.2 pp 53% evidence | 15.5/25 ROCE 9.2% · OPM 11% 57% evidence | 13.8/20 P/E 12.5× · PEG 0.7 65% evidence | 3.0/20 RS sector -45.3% · RS bench -50.3% · 1Y -67.3%1 of 12 weeks ahead 70% evidence |
| Exact sum: 13 + 15.5 + 13.8 + 3 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Freshpet, Inc.FRPT | 45.1/100Mixed-negative evidence61% evidence | TURNING | 20.5/35 Revenue 12.1% · PAT 100% · OPM change 5.9 pp 40% evidence | 6.9/25 ROCE 0.3% · OPM 1.5% 57% evidence | 5.3/20 P/E 15.8× · PEG 2.98 65% evidence | 12.4/20 RS sector 0% · RS bench -6.8% · 1Y -0.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 6.9 + 5.3 + 12.4 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Nomad Foods LimitedNOMD | 43.7/100Thin evidence · provisional60% evidence | BREAKING OUT | 13.3/35 Revenue -2.9% · PAT -40.9% · OPM change -1.8 pp 53% evidence | 10.3/25 ROCE 1.1% · OPM 7.9% 57% evidence | 11.5/20 P/E 9.3× · PEG 1.49 65% evidence | 8.6/20 RS sector -2.1% · RS bench -9.2% · 1Y -26.3%6 of 12 weeks ahead 70% evidence |
| Exact sum: 13.3 + 10.3 + 11.5 + 8.6 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19The Marzetti CompanyMZTI | 40.7/100Mixed-negative evidence66% evidence | BASING | 15.8/35 Revenue 2.8% · PAT 3.5% · OPM change -0.6 pp 53% evidence | 13.4/25 ROCE 4.1% · OPM 10.3% 57% evidence | 8.7/20 P/E 21.6× · PEG 1.71 65% evidence | 2.8/20 RS sector -28.7% · RS bench -34.2% · 1Y -38.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 13.4 + 8.7 + 2.8 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Conagra Brands, Inc.CAG | 39.8/100Thin evidence · provisional56% evidence | TURNING | 15.5/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence | 6.8/25 ROCE -10.8% · OPM 10% 76% evidence | 10.6/20 P/E 11.2× · PEG — 15% evidence | 6.9/20 RS sector -13.1% · RS bench -19.4% · 1Y -22.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 6.8 + 10.6 + 6.9 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Post Holdings, Inc.POST | 38.8/100Mixed-negative evidence66% evidence | BASING | 18.5/35 Revenue 7.2% · PAT -5% · OPM change 1.1 pp 53% evidence | 11.6/25 ROCE 1.8% · OPM 10.4% 57% evidence | 5.6/20 P/E 16.6× · PEG 2.92 65% evidence | 3.1/20 RS sector -13.8% · RS bench -19.6% · 1Y -16.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 11.6 + 5.6 + 3.1 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Flowers Foods, Inc.FLO | 38.3/100Thin evidence · provisional56% evidence | ASLEEP | 16.9/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence | 10.1/25 ROCE 2.3% · OPM 5.1% 76% evidence | 9.4/20 P/E 21.5× · PEG — 15% evidence | 1.9/20 RS sector -31.3% · RS bench -36.7% · 1Y -55.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 10.1 + 9.4 + 1.9 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Pilgrim's Pride CorporationPPC | 33.7/100Thin evidence · provisional56% evidence | BASING | 12.8/35 Revenue — · PAT — · OPM change -5.5 pp 39% evidence | 8.7/25 ROCE 0.9% · OPM 3.6% 76% evidence | 10.2/20 P/E 12.5× · PEG — 15% evidence | 2.0/20 RS sector -29.2% · RS bench -34.5% · 1Y -46%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 8.7 + 10.2 + 2 = 33.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24J&J Snack Foods Corp.JJSF | 33.4/100Thin evidence · provisional60% evidence | BASING | 14.6/35 Revenue -2.1% · PAT -23.7% · OPM change -1.2 pp 53% evidence | 9.0/25 ROCE 0.2% · OPM 0.5% 57% evidence | 3.8/20 P/E 26.8× · PEG 6.43 65% evidence | 6.0/20 RS sector -13.2% · RS bench -19.5% · 1Y -28.1%0 of 12 weeks ahead 70% evidence |
| Exact sum: 14.6 + 9 + 3.8 + 6 = 33.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25General Mills, Inc.GIS | 27.7/100Adverse evidence71% evidence | BASING | 5.8/35 Revenue -5.4% · PAT -103.7% · OPM change -56.5 pp 83% evidence | 6.5/25 ROCE -8.6% · OPM -45.4% 76% evidence | 10.7/20 P/E 10.9× · PEG — 15% evidence | 4.7/20 RS sector -17.9% · RS bench -24% · 1Y -27.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 5.8 + 6.5 + 10.7 + 4.7 = 27.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26The Simply Good Foods CompanySMPL | 23.6/100Adverse evidence65% evidence | ASLEEP | 5.4/35 Revenue -4.5% · PAT -237.2% · OPM change -29.6 pp 83% evidence | 5.7/25 ROCE -2.3% · OPM -14% 76% evidence | 9.2/20 P/E 21.9× · PEG — 15% evidence | 3.3/20 RS sector -38.1% · RS bench -43.3% · 1Y -61.5%1 of 12 weeks ahead 70% evidence |
| Exact sum: 5.4 + 5.7 + 9.2 + 3.3 = 23.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Westrock Coffee CompanyWEST | 52.8/100Thin evidence · provisional48% evidence | ASLEEP | 21.7/35 Revenue 47.3% · PAT — · OPM change 7.1 pp 40% evidence | 7.1/25 ROCE 0.4% · OPM 1% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.0/20 RS sector 34.5% · RS bench 27.8% · 1Y 14.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 7.1 + 10 + 14 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28Herbalife Ltd.HLF | 51.3/100Thin evidence · provisional50% evidence | ASLEEP | 17.6/35 Revenue 3.7% · PAT -15% · OPM change 0.4 pp 53% evidence | 14.8/25 ROCE 8.1% · OPM 10.5% 57% evidence | 11.5/20 P/E 6.5× · PEG — 15% evidence | 7.4/20 RS sector -4.9% · RS bench -10.8% · 1Y 43.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.6 + 14.8 + 11.5 + 7.4 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Once Upon A Farm, PBCthis pageOFRM | 45.1/100Thin evidence · provisional28% evidence | FADING | 19.6/35 Revenue 48.6% · PAT — · OPM change -4 pp 40% evidence | 5.5/25 ROCE -15.8% · OPM -22.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 12 weeks ahead 0% evidence |
| Exact sum: 19.6 + 5.5 + 10 + 10 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30The Magnum Ice Cream Company N.V.MICC | 44.6/100Thin evidence · provisional18% evidence | BREAKING OUT | 16.7/35 Revenue — · PAT — · OPM change — 9% evidence | 9.2/25 ROCE 0.4% · OPM — 46% evidence | 8.7/20 P/E 28.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 16.7 + 9.2 + 8.7 + 10 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Once Upon A Farm, PBC's stock price today?
Once Upon A Farm, PBC trades at $17.2. The company is valued at $1.0 B. The stock sits at 25% of its 52-week range of $15–$24. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. — as of 5 August 2026.
What were Once Upon A Farm, PBC's latest quarterly results?
Once Upon A Farm, PBC reported revenue of $0.1 B and a net loss of $0.0 B for the Mar 26 quarter. Earnings per share were $−0.59. The operating margin was −28.6%, 8.6 pp lower than a year earlier. — as of 5 August 2026.
What is Once Upon A Farm, PBC's revenue?
Once Upon A Farm, PBC reported revenue of $0.1 B in the Mar 26 quarter, +40.0% year on year. For the full FY25 fiscal year, revenue was $0.2 B (+50.0%). Over the last 2 years revenue compounded at 63.3% a year. — as of 5 August 2026.
What is Once Upon A Farm, PBC's profit?
Once Upon A Farm, PBC earned $−0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $−0.0 B. The operating margin ran −28.6% in the latest quarter. — as of 5 August 2026.
What is Once Upon A Farm, PBC's market cap?
Once Upon A Farm, PBC's market capitalisation is $1.0 B at a stock price of $17.2. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Once Upon A Farm, PBC pay a dividend?
No — Once Upon A Farm, PBC has declared no dividend per share in any of its last 9 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
How is Once Upon A Farm, PBC performing?
Once Upon A Farm, PBC's latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 5 August 2026.
Is Once Upon A Farm, PBC beating the market?
On recent form, yes — Once Upon A Farm, PBC has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 6 months the stock moved −21% against the S&P 500's +13% — behind the index over the full window. — as of 5 August 2026.
Will Once Upon A Farm, PBC's stock price go up?
This page publishes no price forecast for Once Upon A Farm, PBC. What it measures instead: the stock price is $17.2. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Once Upon A Farm, PBC?
Yes — short interest is 40.0% of Once Upon A Farm, PBC's tradable float, about 8.1 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
What is Once Upon A Farm, PBC's capex?
Once Upon A Farm, PBC spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.
What is Once Upon A Farm, PBC's cash flow?
Once Upon A Farm, PBC generated $−0.0 B of operating cash flow in FY25 and $−0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.0 B, so operating cash ran behind profit. — as of 5 August 2026.
How financially safe is Once Upon A Farm, PBC?
On the balance sheet, the Z-score reads 11.40 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Once Upon A Farm, PBC in its business cycle?
Once Upon A Farm, PBC's FY25 operating margin was −4.2%, against a 3-year band of −22.2%–−4.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −28.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Once Upon A Farm, PBC story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Once Upon A Farm, PBC a stock worth studying right now?
This is not investment advice. The machine read: Once Upon A Farm, PBC's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.